Industry News
Independent market research says 84% of US Healthcare professionals likely to use Orviglance in target population
Research confirms the unmet need for an effective alternative to unenhanced MRI and a safe alternative to GBCAs
News & Articles
25
Selected Filters:
Industry News
Ascelia Pharma presents study showing comparable efficacy of Orviglance lesion visualization and detection to Gadolinium
Novel contrast agent is being developed to address the medical need of patients with poor kidney function